PharVision Advisers’s Tyler Technologies TYL Stock Holding History

PharVision Advisers’s Portfolio TYL Stock Details TYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-371	Closed	-$216K	–	432
2025 Q1	$216K	Buy	+371	New	+$220K	0.3%	182

Other funds holding TYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PharVision Advisers's TYL Position: Q2 2025 in Review

PharVision Advisers sold out of Tyler Technologies (TYL) in Q2 2025, closing a stake of 371 shares — an estimated $216K sold.

PharVision Advisers first reported a position in TYL in Q1 2025 and held it in 1 quarter. The position peaked at $216K in Q1 2025. 842 funds tracked by Wall St. Rank hold TYL as of Q2 2025.

PharVision Advisers reported no remaining Tyler Technologies position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 371 Tyler Technologies shares in Q2 2025, an estimated $216K.
PharVision Advisers first reported a position in Tyler Technologies in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Tyler Technologies position peaked at $216K in Q1 2025.
842 funds tracked by Wall St. Rank held Tyler Technologies as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.